Industry Research Reports

Home > Reports > Service & Software > Digital Pathology Image Analysis Software for Clinical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Digital Pathology Image Analysis Software for Clinical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-03-12

Pages: 104 Pages

Report ld: 4650764

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Digital Pathology Image Analysis Software for Clinical Market Size(US$)

CAGR 2025-2031

8.8%

Market Size,2031

USD 626

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 378 million

Market Forecast in 2031(Value)

US$ 626 million

CAGR

8.8%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.

Digital Pathology Image Analysis Software for Clinical Use refers to specialized software that assists pathologists in the analysis, interpretation, and quantification of digital images of tissue samples. These images are typically acquired through digital slide scanners, which convert glass slides into high-resolution digital images. The software is designed to support clinical decision-making by enhancing diagnostic accuracy, automating time-consuming tasks, and providing advanced tools for quantitative analysis.

North American market for Digital Pathology Image Analysis Software for Clinical was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Digital Pathology Image Analysis Software for Clinical was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Digital Pathology Image Analysis Software for Clinical was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Digital Pathology Image Analysis Software for Clinical include Indica Labs, Visiopharm, Leica Biosystems, Media Cybernetics, DSA, QuPath, Visio Pharm, 4D Path, Hologic, Gestalt Diagnostics, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Digital Pathology Image Analysis Software for Clinical, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Digital Pathology Image Analysis Software for Clinical by region & country, by Type, and by Application.

The Digital Pathology Image Analysis Software for Clinical market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Pathology Image Analysis Software for Clinical.

MARKET SEGMENTATION

By Company

Indica Labs
Visiopharm
Leica Biosystems
Media Cybernetics
DSA
QuPath
Visio Pharm
4D Path
Hologic
Gestalt Diagnostics
Proscia
Roche Diagnostics
Dipath
iDeepWise

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Web-base Type
Desktop Type

Segment by Application

Scientific Research
Medical Diagnosis

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Digital Pathology Image Analysis Software for Clinical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Digital Pathology Image Analysis Software for Clinical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Digital Pathology Image Analysis Software for Clinical in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Digital Pathology Image Analysis Software for Clinical Product Introduction

1.2 Global Digital Pathology Image Analysis Software for Clinical Market Size Forecast (2020-2031)

1.3 Digital Pathology Image Analysis Software for Clinical Market Trends & Drivers

1.3.1 Digital Pathology Image Analysis Software for Clinical Industry Trends

1.3.2 Digital Pathology Image Analysis Software for Clinical Market Drivers & Opportunity

1.3.3 Digital Pathology Image Analysis Software for Clinical Market Challenges

1.3.4 Digital Pathology Image Analysis Software for Clinical Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Digital Pathology Image Analysis Software for Clinical Players Revenue Ranking (2024)

2.2 Global Digital Pathology Image Analysis Software for Clinical Revenue by Company (2020-2025)

2.3 Key Companies Digital Pathology Image Analysis Software for Clinical Manufacturing Base Distribution and Headquarters

2.4 Key Companies Digital Pathology Image Analysis Software for Clinical Product Offered

2.5 Key Companies Time to Begin Mass Production of Digital Pathology Image Analysis Software for Clinical

2.6 Digital Pathology Image Analysis Software for Clinical Market Competitive Analysis

2.6.1 Digital Pathology Image Analysis Software for Clinical Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Digital Pathology Image Analysis Software for Clinical Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Pathology Image Analysis Software for Clinical as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Web-base Type

3.1.2 Desktop Type

3.2 Global Digital Pathology Image Analysis Software for Clinical Sales Value by Type

3.2.1 Global Digital Pathology Image Analysis Software for Clinical Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Digital Pathology Image Analysis Software for Clinical Sales Value, by Type (2020-2031)

3.2.3 Global Digital Pathology Image Analysis Software for Clinical Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Scientific Research

4.1.2 Medical Diagnosis

4.2 Global Digital Pathology Image Analysis Software for Clinical Sales Value by Application

4.2.1 Global Digital Pathology Image Analysis Software for Clinical Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Digital Pathology Image Analysis Software for Clinical Sales Value, by Application (2020-2031)

4.2.3 Global Digital Pathology Image Analysis Software for Clinical Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region

5.1.1 Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region (2020-2025)

5.1.3 Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region (2026-2031)

5.1.4 Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

5.2.2 North America Digital Pathology Image Analysis Software for Clinical Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

5.3.2 Europe Digital Pathology Image Analysis Software for Clinical Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

5.4.2 Asia Pacific Digital Pathology Image Analysis Software for Clinical Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

5.5.2 South America Digital Pathology Image Analysis Software for Clinical Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

5.6.2 Middle East & Africa Digital Pathology Image Analysis Software for Clinical Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Digital Pathology Image Analysis Software for Clinical Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

6.3 United States

6.3.1 United States Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

6.3.2 United States Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Digital Pathology Image Analysis Software for Clinical Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

6.4.2 Europe Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Digital Pathology Image Analysis Software for Clinical Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

6.5.2 China Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

6.5.3 China Digital Pathology Image Analysis Software for Clinical Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

6.6.2 Japan Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Digital Pathology Image Analysis Software for Clinical Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

6.7.2 South Korea Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Digital Pathology Image Analysis Software for Clinical Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

6.8.2 Southeast Asia Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Digital Pathology Image Analysis Software for Clinical Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Digital Pathology Image Analysis Software for Clinical Sales Value, 2020-2031

6.9.2 India Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

6.9.3 India Digital Pathology Image Analysis Software for Clinical Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 Indica Labs

7.1.1 Indica Labs Profile

7.1.2 Indica Labs Main Business

7.1.3 Indica Labs Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.1.4 Indica Labs Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.1.5 Indica Labs Recent Developments

7.2 Visiopharm

7.2.1 Visiopharm Profile

7.2.2 Visiopharm Main Business

7.2.3 Visiopharm Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.2.4 Visiopharm Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.2.5 Visiopharm Recent Developments

7.3 Leica Biosystems

7.3.1 Leica Biosystems Profile

7.3.2 Leica Biosystems Main Business

7.3.3 Leica Biosystems Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.3.4 Leica Biosystems Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.3.5 Leica Biosystems Recent Developments

7.4 Media Cybernetics

7.4.1 Media Cybernetics Profile

7.4.2 Media Cybernetics Main Business

7.4.3 Media Cybernetics Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.4.4 Media Cybernetics Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.4.5 Media Cybernetics Recent Developments

7.5 DSA

7.5.1 DSA Profile

7.5.2 DSA Main Business

7.5.3 DSA Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.5.4 DSA Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.5.5 DSA Recent Developments

7.6 QuPath

7.6.1 QuPath Profile

7.6.2 QuPath Main Business

7.6.3 QuPath Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.6.4 QuPath Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.6.5 QuPath Recent Developments

7.7 Visio Pharm

7.7.1 Visio Pharm Profile

7.7.2 Visio Pharm Main Business

7.7.3 Visio Pharm Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.7.4 Visio Pharm Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.7.5 Visio Pharm Recent Developments

7.8 4D Path

7.8.1 4D Path Profile

7.8.2 4D Path Main Business

7.8.3 4D Path Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.8.4 4D Path Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.8.5 4D Path Recent Developments

7.9 Hologic

7.9.1 Hologic Profile

7.9.2 Hologic Main Business

7.9.3 Hologic Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.9.4 Hologic Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.9.5 Hologic Recent Developments

7.10 Gestalt Diagnostics

7.10.1 Gestalt Diagnostics Profile

7.10.2 Gestalt Diagnostics Main Business

7.10.3 Gestalt Diagnostics Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.10.4 Gestalt Diagnostics Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.10.5 Gestalt Diagnostics Recent Developments

7.11 Proscia

7.11.1 Proscia Profile

7.11.2 Proscia Main Business

7.11.3 Proscia Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.11.4 Proscia Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.11.5 Proscia Recent Developments

7.12 Roche Diagnostics

7.12.1 Roche Diagnostics Profile

7.12.2 Roche Diagnostics Main Business

7.12.3 Roche Diagnostics Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.12.4 Roche Diagnostics Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.12.5 Roche Diagnostics Recent Developments

7.13 Dipath

7.13.1 Dipath Profile

7.13.2 Dipath Main Business

7.13.3 Dipath Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.13.4 Dipath Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.13.5 Dipath Recent Developments

7.14 iDeepWise

7.14.1 iDeepWise Profile

7.14.2 iDeepWise Main Business

7.14.3 iDeepWise Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

7.14.4 iDeepWise Digital Pathology Image Analysis Software for Clinical Revenue (US$ Million) & (2020-2025)

7.14.5 iDeepWise Recent Developments

8 Industry Chain Analysis

8.1 Digital Pathology Image Analysis Software for Clinical Industrial Chain

8.2 Digital Pathology Image Analysis Software for Clinical Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Digital Pathology Image Analysis Software for Clinical Sales Model

8.5.2 Sales Channel

8.5.3 Digital Pathology Image Analysis Software for Clinical Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Digital Pathology Image Analysis Software for Clinical Market Trends

Table 2. Digital Pathology Image Analysis Software for Clinical Market Drivers & Opportunity

Table 3. Digital Pathology Image Analysis Software for Clinical Market Challenges

Table 4. Digital Pathology Image Analysis Software for Clinical Market Restraints

Table 5. Global Digital Pathology Image Analysis Software for Clinical Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Digital Pathology Image Analysis Software for Clinical Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Digital Pathology Image Analysis Software for Clinical Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Digital Pathology Image Analysis Software for Clinical Product Type

Table 9. Key Companies Time to Begin Mass Production of Digital Pathology Image Analysis Software for Clinical

Table 10. Global Digital Pathology Image Analysis Software for Clinical Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Pathology Image Analysis Software for Clinical as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Digital Pathology Image Analysis Software for Clinical Sales Market Share in Value by Type (2020-2025)

Table 17. Global Digital Pathology Image Analysis Software for Clinical Sales Market Share in Value by Type (2026-2031)

Table 18. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Digital Pathology Image Analysis Software for Clinical Sales Market Share in Value by Application (2020-2025)

Table 22. Global Digital Pathology Image Analysis Software for Clinical Sales Market Share in Value by Application (2026-2031)

Table 23. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region (2020-2025) & (%)

Table 27. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Digital Pathology Image Analysis Software for Clinical Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Digital Pathology Image Analysis Software for Clinical Sales Value, (2026-2031) & (US$ Million)

Table 31. Indica Labs Basic Information List

Table 32. Indica Labs Description and Business Overview

Table 33. Indica Labs Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 34. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Indica Labs (2020-2025)

Table 35. Indica Labs Recent Developments

Table 36. Visiopharm Basic Information List

Table 37. Visiopharm Description and Business Overview

Table 38. Visiopharm Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 39. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Visiopharm (2020-2025)

Table 40. Visiopharm Recent Developments

Table 41. Leica Biosystems Basic Information List

Table 42. Leica Biosystems Description and Business Overview

Table 43. Leica Biosystems Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 44. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Leica Biosystems (2020-2025)

Table 45. Leica Biosystems Recent Developments

Table 46. Media Cybernetics Basic Information List

Table 47. Media Cybernetics Description and Business Overview

Table 48. Media Cybernetics Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 49. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Media Cybernetics (2020-2025)

Table 50. Media Cybernetics Recent Developments

Table 51. DSA Basic Information List

Table 52. DSA Description and Business Overview

Table 53. DSA Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 54. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of DSA (2020-2025)

Table 55. DSA Recent Developments

Table 56. QuPath Basic Information List

Table 57. QuPath Description and Business Overview

Table 58. QuPath Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 59. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of QuPath (2020-2025)

Table 60. QuPath Recent Developments

Table 61. Visio Pharm Basic Information List

Table 62. Visio Pharm Description and Business Overview

Table 63. Visio Pharm Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 64. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Visio Pharm (2020-2025)

Table 65. Visio Pharm Recent Developments

Table 66. 4D Path Basic Information List

Table 67. 4D Path Description and Business Overview

Table 68. 4D Path Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 69. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of 4D Path (2020-2025)

Table 70. 4D Path Recent Developments

Table 71. Hologic Basic Information List

Table 72. Hologic Description and Business Overview

Table 73. Hologic Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 74. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Hologic (2020-2025)

Table 75. Hologic Recent Developments

Table 76. Gestalt Diagnostics Basic Information List

Table 77. Gestalt Diagnostics Description and Business Overview

Table 78. Gestalt Diagnostics Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 79. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Gestalt Diagnostics (2020-2025)

Table 80. Gestalt Diagnostics Recent Developments

Table 81. Proscia Basic Information List

Table 82. Proscia Description and Business Overview

Table 83. Proscia Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 84. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Proscia (2020-2025)

Table 85. Proscia Recent Developments

Table 86. Roche Diagnostics Basic Information List

Table 87. Roche Diagnostics Description and Business Overview

Table 88. Roche Diagnostics Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 89. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Roche Diagnostics (2020-2025)

Table 90. Roche Diagnostics Recent Developments

Table 91. Dipath Basic Information List

Table 92. Dipath Description and Business Overview

Table 93. Dipath Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 94. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of Dipath (2020-2025)

Table 95. Dipath Recent Developments

Table 96. iDeepWise Basic Information List

Table 97. iDeepWise Description and Business Overview

Table 98. iDeepWise Digital Pathology Image Analysis Software for Clinical Products, Services and Solutions

Table 99. Revenue (US$ Million) in Digital Pathology Image Analysis Software for Clinical Business of iDeepWise (2020-2025)

Table 100. iDeepWise Recent Developments

Table 101. Key Raw Materials Lists

Table 102. Raw Materials Key Suppliers Lists

Table 103. Digital Pathology Image Analysis Software for Clinical Downstream Customers

Table 104. Digital Pathology Image Analysis Software for Clinical Distributors List

Table 105. Research Programs/Design for This Report

Table 106. Key Data Information from Secondary Sources

Table 107. Key Data Information from Primary Sources

List of Figures

Figure 1. Digital Pathology Image Analysis Software for Clinical Product Picture

Figure 2. Global Digital Pathology Image Analysis Software for Clinical Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Digital Pathology Image Analysis Software for Clinical Sales Value (2020-2031) & (US$ Million)

Figure 4. Digital Pathology Image Analysis Software for Clinical Report Years Considered

Figure 5. Global Digital Pathology Image Analysis Software for Clinical Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Digital Pathology Image Analysis Software for Clinical Revenue in 2024

Figure 7. Digital Pathology Image Analysis Software for Clinical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Web-base Type Picture

Figure 9. Desktop Type Picture

Figure 10. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Digital Pathology Image Analysis Software for Clinical Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Scientific Research

Figure 13. Product Picture of Medical Diagnosis

Figure 14. Global Digital Pathology Image Analysis Software for Clinical Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 15. Global Digital Pathology Image Analysis Software for Clinical Sales Value Market Share by Application, 2024 & 2031

Figure 16. North America Digital Pathology Image Analysis Software for Clinical Sales Value (2020-2031) & (US$ Million)

Figure 17. North America Digital Pathology Image Analysis Software for Clinical Sales Value by Country (%), 2024 VS 2031

Figure 18. Europe Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 19. Europe Digital Pathology Image Analysis Software for Clinical Sales Value by Country (%), 2024 VS 2031

Figure 20. Asia Pacific Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 21. Asia Pacific Digital Pathology Image Analysis Software for Clinical Sales Value by Region (%), 2024 VS 2031

Figure 22. South America Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 23. South America Digital Pathology Image Analysis Software for Clinical Sales Value by Country (%), 2024 VS 2031

Figure 24. Middle East & Africa Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 25. Middle East & Africa Digital Pathology Image Analysis Software for Clinical Sales Value by Country (%), 2024 VS 2031

Figure 26. Key Countries/Regions Digital Pathology Image Analysis Software for Clinical Sales Value (%), (2020-2031)

Figure 27. United States Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 28. United States Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

Figure 29. United States Digital Pathology Image Analysis Software for Clinical Sales Value by Application (%), 2024 VS 2031

Figure 30. Europe Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 31. Europe Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

Figure 32. Europe Digital Pathology Image Analysis Software for Clinical Sales Value by Application (%), 2024 VS 2031

Figure 33. China Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 34. China Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

Figure 35. China Digital Pathology Image Analysis Software for Clinical Sales Value by Application (%), 2024 VS 2031

Figure 36. Japan Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 37. Japan Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

Figure 38. Japan Digital Pathology Image Analysis Software for Clinical Sales Value by Application (%), 2024 VS 2031

Figure 39. South Korea Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 40. South Korea Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

Figure 41. South Korea Digital Pathology Image Analysis Software for Clinical Sales Value by Application (%), 2024 VS 2031

Figure 42. Southeast Asia Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

Figure 44. Southeast Asia Digital Pathology Image Analysis Software for Clinical Sales Value by Application (%), 2024 VS 2031

Figure 45. India Digital Pathology Image Analysis Software for Clinical Sales Value, (2020-2031) & (US$ Million)

Figure 46. India Digital Pathology Image Analysis Software for Clinical Sales Value by Type (%), 2024 VS 2031

Figure 47. India Digital Pathology Image Analysis Software for Clinical Sales Value by Application (%), 2024 VS 2031

Figure 48. Digital Pathology Image Analysis Software for Clinical Industrial Chain

Figure 49. Digital Pathology Image Analysis Software for Clinical Manufacturing Cost Structure

Figure 50. Channels of Distribution (Direct Sales, and Distribution)

Figure 51. Bottom-up and Top-down Approaches for This Report

Figure 52. Data Triangulation

Figure 53. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Digital Pathology Image Analysis Software for Clinical in 2031? zhanKai

The global market size of Digital Pathology Image Analysis Software for Clinical in 2031 was 626 Million USD.

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global Digital Pathology Image Analysis Software for Clinical market size from 2025 to 2031? shouQi

What was the global market size of Digital Pathology Image Analysis Software for Clinical in 2025? shouQi

Which companies rank high in the global Digital Pathology Image Analysis Software for Clinical market? shouQi

Related Reports

Global Digital Pathology Image Analysis Software for Clinical Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 378 million in 2025 to US$ 675 million by 2032, at a CAGR of 8.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-24
Pages: 132
USD 4900.00
(Single User License)
Global Digital Pathology Image Analysis Software for Clinical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 675 million by 2032 with a CAGR of 8.8% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 95
USD 4250.00
(Single User License)
Digital Pathology Image Analysis Software for Clinical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 675 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 102
USD 3950.00
(Single User License)
Global Digital Pathology Image Analysis Software for Clinical Market Research Report 2026
The global Digital Pathology Image Analysis Software for Clinical market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 675 million by 2032, at a CAGR of 8.8% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 117
USD 2900.00
(Single User License)
Global Digital Pathology Image Analysis Software for Clinical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 93
USD 4250.00
(Single User License)
Global Digital Pathology Image Analysis Software for Clinical Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 351 million in 2024 to US$ 626 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 133
USD 4900.00
(Single User License)
Global Digital Pathology Image Analysis Software for Clinical Market Research Report 2025
The global market for Digital Pathology Image Analysis Software for Clinical was valued at US$ 351 million in the year 2024 and is projected to reach a revised size of US$ 626 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published Date: 2025-03-12
Pages: 90
USD 2900.00
(Single User License)
Global and United States Digital Pathology Image Analysis Software for Clinical Market Report & Forecast 2024-2030
The global Digital Pathology Image Analysis Software for Clinical revenue was US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published Date: 2024-12-12
Pages: 120
USD 4350.00
(Single User License)
Digital Pathology Image Analysis Software for Clinical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published Date: 2024-12-12
Pages: 119
USD 3950.00
(Single User License)
Global Digital Pathology Image Analysis Software for Clinical Market Insights, Forecast to 2030
Valued at US$ 351 million in 2024, the global Digital Pathology Image Analysis Software for Clinical market is forecast to reach US$ 580 million by 2030, at a CAGR of 8.8% during the forecast period.
Published Date: 2024-12-12
Pages: 139
USD 4900.00
(Single User License)

Global Digital Pathology Image Analysis Software for Clinical Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 378 million in 2025 to US$ 675 million by 2032, at a CAGR of 8.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-24
Pages: 132
USD 4900.00 (Single User License)
Global Digital Pathology Image Analysis Software for Clinical Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 378 million in 2025 and is forecast to reach a readjusted size of US$ 675 million by 2032 with a CAGR of 8.8% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 95
USD 4250.00 (Single User License)
Digital Pathology Image Analysis Software for Clinical - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 378 million in 2025 and is projected to reach US$ 675 million, growing at a CAGR of 8.8% from 2026 to 2032.
Published: 2026-01-19
Pages: 102
USD 3950.00 (Single User License)
Global Digital Pathology Image Analysis Software for Clinical Market Research Report 2026
The global Digital Pathology Image Analysis Software for Clinical market was valued at US$ 378 million in 2025 and is anticipated to reach US$ 675 million by 2032, at a CAGR of 8.8% from 2026 to 2032.
Published: 2026-01-08
Pages: 117
USD 2900.00 (Single User License)
Global Digital Pathology Image Analysis Software for Clinical Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Digital Pathology Image Analysis Software for Clinical market size was US$ 351 million in 2024 and is forecast to a readjusted size of US$ 626 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 93
USD 4250.00 (Single User License)
Global Digital Pathology Image Analysis Software for Clinical Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Digital Pathology Image Analysis Software for Clinical market is projected to grow from US$ 351 million in 2024 to US$ 626 million by 2031, at a CAGR of 8.8% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 133
USD 4900.00 (Single User License)
Global Digital Pathology Image Analysis Software for Clinical Market Research Report 2025
The global market for Digital Pathology Image Analysis Software for Clinical was valued at US$ 351 million in the year 2024 and is projected to reach a revised size of US$ 626 million by 2031, growing at a CAGR of 8.8% during the forecast period.
Published: 2025-03-12
Pages: 90
USD 2900.00 (Single User License)
Global and United States Digital Pathology Image Analysis Software for Clinical Market Report & Forecast 2024-2030
The global Digital Pathology Image Analysis Software for Clinical revenue was US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the review period (2024-2030).
Published: 2024-12-12
Pages: 120
USD 4350.00 (Single User License)
Digital Pathology Image Analysis Software for Clinical- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Digital Pathology Image Analysis Software for Clinical was estimated to be worth US$ 330 million in 2023 and is forecast to a readjusted size of US$ 580 million by 2030 with a CAGR of 8.8% during the forecast period 2024-2030.
Published: 2024-12-12
Pages: 119
USD 3950.00 (Single User License)
Global Digital Pathology Image Analysis Software for Clinical Market Insights, Forecast to 2030
Valued at US$ 351 million in 2024, the global Digital Pathology Image Analysis Software for Clinical market is forecast to reach US$ 580 million by 2030, at a CAGR of 8.8% during the forecast period.
Published: 2024-12-12
Pages: 139
USD 4900.00 (Single User License)